| scholarly article | Q13442814 |
| P50 | author | Anders Løbner-Olesen | Q59657103 |
| P2093 | author name string | Luca Guardabassi | |
| Bimal Jana | |||
| Rasmus N Klitgaard | |||
| Karen L Nielsen | |||
| P2860 | cites work | After 30 years of study, the bacterial SOS response still surprises us | Q21092806 |
| Inhibition of mutation and combating the evolution of antibiotic resistance | Q21146100 | ||
| Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection | Q22122301 | ||
| Unnecessary use of fluoroquinolone antibiotics in hospitalized patients | Q27496669 | ||
| RecA Inhibitors Potentiate Antibiotic Activity and Block Evolution of Antibiotic Resistance. | Q50868599 | ||
| Binding site feature description of 2-substituted benzothiazoles as potential AcrAB-TolC efflux pump inhibitors in E. coli. | Q53809684 | ||
| A DNA architectural protein couples cellular physiology and DNA topology in Escherichia coli | Q73265521 | ||
| The quinolones: decades of development and use | Q28191758 | ||
| Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents | Q28306539 | ||
| Interplay in the selection of fluoroquinolone resistance and bacterial fitness | Q28475870 | ||
| Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation | Q28540748 | ||
| Computational analysis of bacterial RNA-Seq data | Q28686251 | ||
| Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code | Q33768891 | ||
| Escherichia coli ST131, an intriguing clonal group | Q34057648 | ||
| Exonuclease VII of Escherichia coli. Mechanism of action | Q34214372 | ||
| Fluoroquinolone prescribing in the United States: 1995 to 2002. | Q34399799 | ||
| Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli | Q35046034 | ||
| Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent | Q35630491 | ||
| Targets for Combating the Evolution of Acquired Antibiotic Resistance | Q35754447 | ||
| De Novo Characterization of Genes That Contribute to High-Level Ciprofloxacin Resistance in Escherichia coli | Q36080959 | ||
| Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. | Q36172185 | ||
| Global fluoroquinolone resistance epidemiology and implictions for clinical use. | Q36337074 | ||
| Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains | Q36492372 | ||
| Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli | Q36845531 | ||
| Quinolone-mediated bacterial death. | Q36921143 | ||
| Mechanism of quinolone action and resistance | Q37701591 | ||
| Antimicrobials as promoters of genetic variation | Q38034384 | ||
| Plasmid-mediated quinolone resistance: Two decades on. | Q39027430 | ||
| High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. | Q39475770 | ||
| Pimozide Inhibits the AcrAB-TolC Efflux Pump in Escherichia coli | Q39494097 | ||
| RuvA, RuvB and RuvC proteins: cleaning-up after recombinational repairs in E. coli | Q40856449 | ||
| Oxidative DNA damage is instrumental in hyperreplication stress-induced inviability of Escherichia coli. | Q41811490 | ||
| Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications. | Q42244321 | ||
| Quinolone Resistance Reversion by Targeting the SOS Response. | Q42264036 | ||
| Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India | Q42849959 | ||
| Impact of the RNA chaperone Hfq on multidrug resistance in Escherichia coli | Q43138281 | ||
| Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy. | Q43178447 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Escherichia coli K-12 | Q21399437 |
| P304 | page(s) | 1438 | |
| P577 | publication date | 2018-07-02 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | DNA Damage Repair and Drug Efflux as Potential Targets for Reversing Low or Intermediate Ciprofloxacin Resistance in E. coli K-12 | |
| P478 | volume | 9 |
| Q97421941 | A systematic strategy for the investigation of vaccines and drugs targeting bacteria |
| Q64899477 | Betulinic Acid Prevents the Acquisition of Ciprofloxacin-Mediated Mutagenesis in Staphylococcus aureus. |
| Q92279146 | The response of Escherichia coli to the alkylating agents chloroacetaldehyde and styrene oxide |
Search more.